mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.003 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
0.18 |
0.003 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.16 |
0.003 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
-0.4 |
0.004 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
OSU-03012 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.005 |